Literature DB >> 23634238

Invasive catheterization of the hepatic artery for preclinical investigation of liver-directed therapies in rodent models of liver cancer.

Alexander Y Sheu1, Zhuoli Zhang, Reed A Omary, Andrew C Larson.   

Abstract

PURPOSE: This study demonstrated invasive and reproducible hepatic artery catheterization in rats. A rigorously documented guide and pictorial essay describes the performance of an invasive hepatic artery catheterization technique suitable for the study of liver-targeted interventional procedures in rodent models of liver cancer. The goal was to produce a well-illustrated guide to hepatic artery catheterization under direct visualization via the gastroduodenal artery (GDA).
MATERIALS AND METHODS: 20 Sprague Dawley rats were inoculated with McA-RH7777 HCC cells in the left lateral liver lobe. Magnetic resonance imaging (MRI) was used to measure tumor growth. Catheter placement in the hepatic artery proper was performed by entry through the GDA under direct visualization after laparotomy. Digital subtraction angiography confirmed catheter placement in the hepatic artery proper. Antegrade blood flow to the liver was restored after catheter removal. Rats were euthanized after procedures; livers were harvested for hematoxylin and eosin (H&E) staining.
RESULTS: 85.0% of inoculated animals developed measurable tumors on MRI; average tumor size was 6.3 ± 2.3 mm × 4.3 ± 1.5 mm (mean ± SD). 94.1% of animals with tumors were successfully catheterized. H&E staining demonstrated tumor growth in all inoculated animals, including those with no measurable tumors on MRI.
CONCLUSION: Invasive catheter placement in the hepatic artery of a rodent model of HCC can be performed reproducibly according to the techniques described in this tutorial. These catheterization techniques are ideal for a broad range of preclinical IR studies intending to evaluate the efficacy of intra-arterial therapies for the treatment of primary and metastatic liver tumors.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); McA-RH7777; catheterization; intra-arterial (IA); rodent model

Year:  2013        PMID: 23634238      PMCID: PMC3633970     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  17 in total

1.  Eradication of advanced hepatocellular carcinoma in rats via repeated hepatic arterial infusions of recombinant VSV.

Authors:  Katsunori Shinozaki; Oliver Ebert; Savio L C Woo
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

2.  A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.

Authors:  R J Lewandowski; L M Kulik; A Riaz; S Senthilnathan; M F Mulcahy; R K Ryu; S M Ibrahim; K T Sato; T Baker; F H Miller; R Omary; M Abecassis; R Salem
Journal:  Am J Transplant       Date:  2009-06-22       Impact factor: 8.086

3.  Establishment of an in vitro cell line from the rabbit VX2 carcinoma.

Authors:  D M Easty; G C Easty
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1982

4.  An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features.

Authors:  Xin Li; Chuan-Sheng Zheng; Gan-Sheng Feng; Chen-Kai Zhuo; Jun-Gong Zhao; Xi Liu
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Catheterization of the hepatic artery via the left common carotid artery in rats.

Authors:  Xiao Li; Yi-Xiang J Wang; Xiangping Zhou; Yongsong Guan; Chengwei Tang
Journal:  Cardiovasc Intervent Radiol       Date:  2006 Nov-Dec       Impact factor: 2.740

6.  Oncolysis of multifocal hepatocellular carcinoma in the rat liver by hepatic artery infusion of vesicular stomatitis virus.

Authors:  Katsunori Shinozaki; Oliver Ebert; Chryssanthi Kournioti; Yun-Sheng Tai; Savio L C Woo
Journal:  Mol Ther       Date:  2004-03       Impact factor: 11.454

Review 7.  Review article: the management of hepatocellular carcinoma.

Authors:  R Cabrera; D R Nelson
Journal:  Aliment Pharmacol Ther       Date:  2009-11-19       Impact factor: 8.171

8.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

Review 9.  Animal models of cancer in interventional radiology.

Authors:  Rajagopal N Aravalli; Jafar Golzarian; Erik N K Cressman
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

10.  Technical aspects of imaging and transfemoral arterial treatment of N1-S1 tumors in rats: an appropriate model to test the biology and therapeutic response to transarterial treatments of liver cancers.

Authors:  Shenghong Ju; Gordon McLennan; Stacy L Bennett; Yun Liang; Laurent Bonnac; Krzysztof W Pankiewicz; Hiremagalur N Jayaram
Journal:  J Vasc Interv Radiol       Date:  2009-01-23       Impact factor: 3.464

View more
  7 in total

1.  Development and Validation of Sorafenib-eluting Microspheres to Enhance Therapeutic Efficacy of Transcatheter Arterial Chemoembolization in a Rat Model of Hepatocellular Carcinoma.

Authors:  Wooram Park; Soojeong Cho; Jingran Ji; Robert J Lewandowski; Andrew C Larson; Dong-Hyun Kim
Journal:  Radiol Imaging Cancer       Date:  2021-01-08

2.  Acidic pH-Triggered Drug-Eluting Nanocomposites for Magnetic Resonance Imaging-Monitored Intra-arterial Drug Delivery to Hepatocellular Carcinoma.

Authors:  Wooram Park; Jeane Chen; Soojeong Cho; Sin-Jung Park; Andrew C Larson; Kun Na; Dong-Hyun Kim
Journal:  ACS Appl Mater Interfaces       Date:  2016-05-16       Impact factor: 9.229

Review 3.  Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications.

Authors:  Alphonse E Sirica; Jorge A Almenara; Chao Li
Journal:  Exp Mol Pathol       Date:  2014-10-28       Impact factor: 3.362

4.  Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors.

Authors:  Jeane Chen; Alexander Y Sheu; Weiguo Li; Zhuoli Zhang; Dong-Hyun Kim; Robert J Lewandowski; Reed A Omary; Lonnie D Shea; Andrew C Larson
Journal:  J Control Release       Date:  2014-04-13       Impact factor: 9.776

5.  An implanted port-catheter system for repeated hepatic arterial infusion of low-density lipoprotein-docosahexaenoic acid nanoparticles in normal rats: A safety study.

Authors:  Yuzhu Wang; Junjie Li; Indhumathy Subramaniyan; Goncalo Dias do Vale; Jaideep Chaudhary; Arnida Anwar; Mary Wight-Carter; Jeffrey G McDonald; William C Putnam; Tao Qin; Hongwei Zhang; Ian R Corbin
Journal:  Toxicol Appl Pharmacol       Date:  2020-05-15       Impact factor: 4.219

6.  Vascular Interventional Radiology-Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods.

Authors:  Abdul Kareem Parchur; Gayatri Sharma; Jaidip M Jagtap; Venkateswara Rao Gogineni; Peter S LaViolette; Michael J Flister; Sarah Beth White; Amit Joshi
Journal:  ACS Nano       Date:  2018-07-06       Impact factor: 18.027

7.  MRI-guided interventional natural killer cell delivery for liver tumor treatment.

Authors:  Zhanliang Su; Xifu Wang; Linfeng Zheng; Tianchu Lyu; Matteo Figini; Bin Wang; Daniel Procissi; Junjie Shangguan; Chong Sun; Liang Pan; Lei Qin; Bin Zhang; Yury Velichko; Riad Salem; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Cancer Med       Date:  2018-03-30       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.